Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2018 Aug 29;10:3057–3067. doi: 10.2147/CMAR.S167781

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2018 Chen et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

Endogenous mRNA level of CPNE3 in advanced hepatocellular carcinoma (HCC) tissues related to clinical outcome of patients who received sorafenib treatment.

Notes: (A and B) Endogenous mRNA level of CPNE3 was identified by quantitative polymerase chain reaction (qPCR) as relative RNA (A) or represented DNA electrophoresis bands from ten representative specimens (five high and five low) (B). (C) OS of patients who received sorafenib. (D) Time to progress of patients who received sorafenib. (C and D) Survival analysis was conducted using the Kaplan–Meier and log-rank test. (A) ^*P<0.05 versus CPNE3 high group or CPNE3 low group; (C) P=0.0025 versus CPNE3 high group or CPNE3 low group; (D) P=0.0004 versus CPNE3 high group or CPNE3 low group.